These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
542 related articles for article (PubMed ID: 2403650)
1. Leukemia following Hodgkin's disease. Kaldor JM; Day NE; Clarke EA; Van Leeuwen FE; Henry-Amar M; Fiorentino MV; Bell J; Pedersen D; Band P; Assouline D N Engl J Med; 1990 Jan; 322(1):7-13. PubMed ID: 2403650 [TBL] [Abstract][Full Text] [Related]
2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study. Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578 [TBL] [Abstract][Full Text] [Related]
3. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia. Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437 [TBL] [Abstract][Full Text] [Related]
4. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. Blayney DW; Longo DL; Young RC; Greene MH; Hubbard SM; Postal MG; Duffey PL; DeVita VT N Engl J Med; 1987 Mar; 316(12):710-4. PubMed ID: 3821809 [TBL] [Abstract][Full Text] [Related]
5. Leukemia following chemotherapy for ovarian cancer. Kaldor JM; Day NE; Pettersson F; Clarke EA; Pedersen D; Mehnert W; Bell J; Høst H; Prior P; Karjalainen S N Engl J Med; 1990 Jan; 322(1):1-6. PubMed ID: 2104664 [TBL] [Abstract][Full Text] [Related]
6. Acute leukemia after the treatment of Hodgkin's disease. Henry-Amar M; Dietrich PY Hematol Oncol Clin North Am; 1993 Apr; 7(2):369-87. PubMed ID: 8468271 [TBL] [Abstract][Full Text] [Related]
7. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors. Meadows AT; Obringer AC; Marrero O; Oberlin O; Robison L; Fossati-Bellani F; Green D; Voûte PA; Morris-Jones P; Greenberg M Med Pediatr Oncol; 1989; 17(6):477-84. PubMed ID: 2586362 [TBL] [Abstract][Full Text] [Related]
8. Risk of second cancers after treatment for Hodgkin's disease. Tucker MA; Coleman CN; Cox RS; Varghese A; Rosenberg SA N Engl J Med; 1988 Jan; 318(2):76-81. PubMed ID: 3336397 [TBL] [Abstract][Full Text] [Related]
10. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma]. Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946 [TBL] [Abstract][Full Text] [Related]
11. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease. Henry-Amar M J Natl Cancer Inst; 1983 Nov; 71(5):911-6. PubMed ID: 6580491 [TBL] [Abstract][Full Text] [Related]
12. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD. Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040 [TBL] [Abstract][Full Text] [Related]
13. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452 [TBL] [Abstract][Full Text] [Related]
14. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the risk of solid tumor following Hodgkin's disease. Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C Haematologica; 1997; 82(1):57-63. PubMed ID: 9107084 [TBL] [Abstract][Full Text] [Related]
16. Second malignant tumours in childhood Hodgkin's disease. Jenkin D; Greenberg M; Fitzgerald A Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372 [TBL] [Abstract][Full Text] [Related]
17. Quantitative risk of second cancer in patients in first complete remission from early stages of Hodgkin's disease. Henry-Amar M NCI Monogr; 1988; (6):65-72. PubMed ID: 3352791 [TBL] [Abstract][Full Text] [Related]
18. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute. Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481 [TBL] [Abstract][Full Text] [Related]
19. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic]. Mjaaland I; Ganser D; Freitag EM; Bohndorf W Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173 [TBL] [Abstract][Full Text] [Related]
20. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N Engl J Med; 1987 Sep; 317(11):707-9. PubMed ID: 3627177 [No Abstract] [Full Text] [Related] [Next] [New Search]